Taro Pharm Inds (TARO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 130,498 | 156,665 | 143,264 | 138,984 | 131,986 |
| Cost of Goods | 83,536 | 75,059 | 65,919 | 62,950 | 69,941 |
| Gross Profit | 46,962 | 81,606 | 77,345 | 76,034 | 62,045 |
| Operating Expenses | 54,313 | 67,689 | 56,987 | 40,018 | 38,540 |
| Operating Income | -6,815 | 13,976 | 21,277 | 36,966 | 24,446 |
| Other Income | 1,902 | 2,077 | 3,738 | 2,535 | 4,975 |
| Pre-tax Income | -4,913 | 16,053 | 25,015 | 39,501 | 29,421 |
| Income Tax | -2,100 | 1,974 | -2,388 | 13,188 | 6,104 |
| Net Income Continuous | -2,813 | 14,079 | 27,403 | 26,313 | 23,317 |
| Net Income | $-2,813 | $14,079 | $27,403 | $26,313 | $23,317 |
| EPS Basic Total Ops | -0.07 | 0.37 | 0.73 | 0.70 | 0.62 |
| EPS Basic Continuous Ops | -0.07 | 0.37 | 0.72 | 0.70 | 0.62 |
| EPS Diluted Total Ops | -0.07 | 0.37 | 0.73 | 0.70 | 0.62 |
| EPS Diluted Continuous Ops | -0.07 | 0.37 | 0.72 | 0.70 | 0.62 |
| EPS Diluted Before Non-Recurring Items | -0.07 | 0.37 | N/A | N/A | N/A |
| EBITDA(a) | $7,141 | $20,954 | $33,549 | $51,153 | $28,716 |